Redeye updates its estimates and valuation following ADDvise releasing its Q1 2024 report, which fea...
Redeye updates its estimates and valuation following Vitec releasing its Q1 2024 report.
Including Brage acquisition in our estimates Løvmeis exploration well in Q3'24 - the next big event ...
Q1 weaker than expected... ...but outlook remains bright Low valuation and leverage on market, lower...
Plejds nettoomsättning för det fjärde kvartalet 2023 uppgick till 159,0 MSEK (121,3), en ökning med ...
Arctic Blue Beverages AB (”Arctic Blue Beverages” eller ”Bolaget”) meddelade den 18 april 2024 att B...
Redeye presents its preview of Sedana Medical’s Q1 2024 report, due on April 25.
Redeye revisits its market share assumptions for BONESUPPORT’s extremities business.
Redeye comments on Safeture's Q1 2024 report, which was stable despite higher churn.
Redeye strengthens its positive view of Vertiseit following a solid Q1 report, new long-term goals, ...
Redeye provides a research update following the Q1 report recently published by Magle.
Redeye comments on Freemelt’s first industrial printer (eMelt) order in the US and provides a previe...
Q1e: Clean EBIT of PLN 87m Paper is improving – better demand and 10% supply cuts Fair value range o...
We cut '24e-'26e adj. EBITA by 8-4% Should break seven-quarter negative org.
Solid Q1 with 33% ARR growth and 15% adj. EBITDA margin Raising '24e-'26e ARR by ~1%, EBITDA by 19-1...
Tangiamo Touch Technology meddelade den 16 april 2024 att bolaget har erhållit en order värd cirka 1...
Inför Q1: marknadsdata indikerar underliggande tillväxt i Sverige Vi förväntar oss en omsättningstil...
Fastighetsmarknaden har en alltmer balanserad antydan och fastighetsbolaget fortsätter att stärka up...
The recorded sales growth is 0% in local currency due to an extended headwind for the Genetics busin...
Wood M&A lifts '24e-'26e EPS by 4-6%, EBITA up 12-17% Share now trading at 9.
